SBI Life Insurance Company

Investment case

Lowest-cost, highest-persistency

Why this business

India's largest private life insurer (55.3% owned by State Bank of India), with a 22.9% private-sector market share on individual rated premium and 25.5% on individual new business in FY26. FY26 APE was Rs 24,270 crore (+13%), VNB Rs 6,670 crore at a 27.5% margin, embedded value Rs 80,790 crore (+15%) and AUM Rs 4.87 lakh crore. SBI's 22,000+ branch network supplies ~60% of APE via bancassurance, supplemented by a fast-growing agency channel; the product mix is ULIP-heavy (60% of FY26 APE) but non-par rose to 49% of Q1FY27 APE.

What we believe

1. 01Growth re-accelerating on distribution diversification: Q1FY27 APE +36% (individual rated NBP +14%, agency +20%, banca +10%) and Aug-2026 individual APE +21.8%, the highest among the four listed private insurers.
2. 02Margin resilience despite GST/ITC loss: VNB margin 26.2% in Q1FY27 (27.4% ex-GST) with guidance of 26-28% for FY27; non-par share of APE rose to 49% from 38% and pure protection APE +41%.
3. 03Scale and cost leadership: largest private insurer (22.9% private IRP share), FY26 EV Rs 80,790 cr (+15%) with 19.7% operating RoEV, solvency 1.96x, lowest mis-selling ratio (0.02%) and 87.7% 13-month persistency.
4. 04Earnings visibility: Axis Direct forecasts EPS of Rs 28.3/37.5 for FY27/FY28 (23% CAGR from FY26's Rs 24.63) as the back book unwinds; street TPs Rs 2,350-2,600 vs Rs 1,732 (27-50% upside).
5. 05Cheapest large-cap access to the SBI franchise: SBI's 22,000+ branches (60% of APE) at 1.8x FY27E EV, a lower multiple than Max Financial (1.9x) with a stronger balance sheet and no holdco/structure risk.

Why now

At Rs 1,732 the stock is ~2.0x trailing EV (Rs 85,290 cr, Jun-2026) and 1.8x/1.5x FY27E/FY28E P/EV (Nuvama) vs HDFC Life at 1.6x/1.4x - a ~0.2x premium for 20%+ APE growth vs HDFC Life's 17%; Axis Direct trimmed its target multiple to 2.1x from 2.2x FY28E EV. Own 5y average P/EV not sourced. EV/EBITDA n.m.; dividend yield 0.2%.

Market disagreement

• HDFC Life: HDFC Life (59x PE, ROE 11.3%, Nuvama P/EV 1.6x/1.4x) grew FY26 VNB only 2% and Aug-2026 individual APE 17.4% vs SBI Life's 12% and 21.8%; SBI Life's 0.2x P/EV premium is paid for faster VNB growth, a higher operating RoEV (19.7%) and SBI's captive distribution.
• LIC: LIC is optically cheap (8.7x PE, ROE 37.8%, FY26 VNB +41.6% to Rs 14,179 cr) but carries a state-owned agency-only model, a 56.7% but falling NBP share, low free float and less EV growth predictability; SBI Life offers cleaner private-sector governance and a 20%+ APE growth engine.

Position sizing

Core Large cap  1.1% of the PMS on $31 Jul 2026 (August rank 26). Core positions are owned through the cycle for leadership and cash-flow quality.

Catalysts

• H1FY27 results (late Oct-2026): margin recovery toward 27-28% guidance as group business normalises and non-par mix stays high.
• Monthly IRDAI new-business data (Sep-Oct-2026) confirming 20%+ individual APE growth ahead of peers.
• Any IRDAI/GST Council move to restore input-tax credit for insurers, which would reverse the ~120 bps GST margin drag.

Risks and response

• Bancassurance dependence: SBI channel is ~60% of FY26 APE (47% in Q1FY27); any regulatory cap on banca share or a change in SBI's priorities would cut growth.
• ULIP/market sensitivity: ULIPs were 60% of FY26 APE (46% in Q1FY27); an equity-market correction would slow ULIP sales and compress the mix-driven margin, while 61-month persistency fell to 58.4% from 63.6%.
• GST/ITC and product regulation: exemption from 22-Sep-2025 with ITC withdrawal cost ~120 bps of Q1FY27 margin (27.4% ex-GST vs 26.2% reported); further surrender-value or commission rules could pressure VNB.

Thesis-break conditions

Not stated separately on this page; the risk list carries the monitoring triggers.

Review history

• 8 Sep 2026 · Yash Palod · one-pager in "Why We Own What We Own" (p38) · portfolio as of $31 Jul 2026
• 31 Aug 2026 · Classification in the August top-30: Core

Source: Buoyant_Why_We_Own_What_We_Own_Sep2026.pdf (portfolio as of 31 July 2026), p38. Internal; external publication of these fields is controlled by audience policy.